Group One Trading
MBIO icon

Group One Trading’s Mustang Bio MBIO Stock Holding History

Group One Trading’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed -$4K – 7745
2022
Q3 		$4K Sell
12
-4
-25% -$1.85K ﹤0.01% 6934
2022
Q2 		$7K Buy
+16
New +$8.86K ﹤0.01% 6941
2022
Q1 		– Sell
-1
Closed -$1K – 8405
2021
Q4 		$1K Sell
1
-362
-100% -$584K ﹤0.01% 7998
2021
Q3 		$733K Sell
363
-229
-39% -$492K ﹤0.01% 3761
2021
Q2 		$1.48M Buy
592
+469
+381% +$1.15M ﹤0.01% 2960
2021
Q1 		$306K Sell
123
-250
-67% -$743K ﹤0.01% 4554
2020
Q4 		$1.06M Buy
373
+352
+1,676% +$841K ﹤0.01% 2591
2020
Q3 		$50K Buy
21
+10
+91% +$24.6K ﹤0.01% 4642
2020
Q2 		$26K Buy
+11
New +$25.7K ﹤0.01% 4706

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading's MBIO Position: Q1 2026 in Review

Group One Trading held its Mustang Bio (MBIO) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7491.

Group One Trading first reported a position in MBIO in Q2 2019 and has held it in 23 quarters since. The position peaked at $82K in Q4 2020. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Group One Trading held 1 share of Mustang Bio worth $1 as of Q1 2026.
  • Group One Trading left its Mustang Bio share count unchanged in Q1 2026.
  • Mustang Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7491 holding.
  • Group One Trading first reported a position in Mustang Bio in Q2 2019 and has held it in 23 quarters since.
  • Group One Trading's Mustang Bio position peaked at $82K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.